You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 140 No. 6, June 1980 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

In Vitro Activities of β-Lactam and Aminoglycoside Antibiotics

A Comparative Study of 20 Parenterally Administered Drugs

Robert J. Fass, MD

Arch Intern Med. 1980;140(6):763-768.


Abstract



In vitro susceptibilities of 552 recent clinical isolates to 20 parenterally administered β-lactam and aminoglycoside antibiotics were studied. Newer βlactam antibiotics had no increased activity over well-known penicillins and cephalosporins against Gram-positive cocci. All showed greater activity, a broadened spectrum, or both against Gram-negative bacilli; azlocillin, mezlocillin, mecillinam, cefamandole, and cefoxitin each had unique advantages. Against Bacteroides fragilis, mezlocillin was more active than available penicillins, and cefoxitin was more active than available cephalosporins, but neither provided any advantages against other anaerobes. All the aminoglycosides studied were inactive against streptococci and anaerobes but had broad spectrums of activity against staphylococci and Enterobacteriaceae. Activity against Pseudomonas aeruginosa was variable. Sisomicin was the most active aminoglycoside against aminoglycoside-susceptible Gram-negative bacilli, but amikacin inhibited the largest percentage (99.2%) of Enterobacteriaceae and P aeruginosa.

(Arch Intern Med 140:763-768, 1980)



Author Affiliations



From the Division of Infectious Diseases, Department of Medicine, The Ohio State University College of Medicine, Columbus.


Footnotes



Accepted for publication July 3, 1979.

Reprint requests to University Hospital N-1135, 410 W Tenth Ave, Columbus, OH 43210 (Dr Fass).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bacteremias due to Citrobacter diversus and Citrobacter freundii: Incidence, Risk Factors, and Clinical Outcome
Drelichman and Band
Arch Intern Med 1985;145:1808-1810.
ABSTRACT  

Comparative In Vitro Activities of Third-Generation Cephalosporins
Fass
Arch Intern Med 1983;143:1743-1745.
ABSTRACT  

Azlocillin, Mezlocillin, and Piperacillin: New Broad-Spectrum Penicillins
ELIOPOULOS and MOELLERING
ANN INTERN MED 1982;97:755-760.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.